title: Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation.
abstract: We previously introduced the concept that intrahepatic bile duct epithelial cells, or cholangiocytes, are functionally heterogeneous. This concept is based on the observation that secretin receptor (SR) gene expression and secretin-induced cAMP synthesis are present in cholangiocytes derived from large (> 15 microns in diameter) but not small (< 15 microns in diameter) bile ducts. In work reported here, we tested the hypothesis that cholangiocytes are heterogeneous with regard to proliferative capacity. We assessed cholangiocyte proliferation in vivo by measurement of [3H]thymidine incorporation and in vitro by both [3H]thymidine incorporation and H3 histone gene expression in small (fraction 1) and large (fraction 2) cholangiocytes isolated from rats after bile duct ligation (BDL). In the two cholangiocyte subpopulations, we also studied basal somatostatin receptor (SSTR2) gene expression as well as the effects of somatostatin on 1) SR gene expression and secretin-induced cAMP synthesis and 2) [3H]thymidine incorporation and H3 histone gene expression. In normal rat liver, cholangiocytes, unlike hepatocytes, were mitotically dormant; after BDL, incorporation of [3H]thymidine markedly increased in cholangiocytes but not hepatocytes. When subpopulations of cholangiocytes were isolated after BDL, DNA synthesis assessed by both techniques was limited to large cholangiocytes, as was SSTR2 steady-state gene expression. In vitro, somatostatin inhibited SR gene expression and secretin-induced cAMP synthesis only in large cholangiocytes. Moreover, compared with no hormone, somatostatin inhibited DNA synthesis solely in large cholangiocytes. These results support the concept of the heterogeneity of cholangiocytes along the biliary tree, extend this concept to cholangiocyte proliferative activity, and imply that the proliferative compartment of cholangiocytes after BDL is located principally in the cholangiocytes lining large (> 15 microns) bile ducts.
authors.affiliation: Department of Medical Physiology and Internal Medicine, Scott & White Hospital, Temple, Texas, USA.
authors.forename: G
authors.initials: G
authors.lastname: Alpini
authors.forename: S S
authors.initials: SS
authors.lastname: Glaser
authors.forename: Y
authors.initials: Y
authors.lastname: Ueno
authors.forename: L
authors.initials: L
authors.lastname: Pham
authors.forename: P V
authors.initials: PV
authors.lastname: Podila
authors.forename: A
authors.initials: A
authors.lastname: Caligiuri
authors.forename: G
authors.initials: G
authors.lastname: LeSage
authors.forename: N F
authors.initials: NF
authors.lastname: LaRusso
mesh_terms: D000818:Animals; D001345:Autoradiography; D001653:Bile Ducts, Intrahepatic / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D002455:Cell Division / Q000502:physiology; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D006657:Histones / Q000235:genetics; D007150:Immunohistochemistry; D008026:Ligation; D008297:Male; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D017481:Receptors, Somatostatin / Q000235:genetics; D012633:Secretin / Q000494:pharmacology; D013004:Somatostatin / Q000494:pharmacology; D013936:Thymidine / Q000493:pharmacokinetics
chemical_list: D006657:Histones; D012333:RNA, Messenger; D017481:Receptors, Somatostatin; D012633:Secretin; D013004:Somatostatin; D013936:Thymidine